Brief: Mabion Gets Additional Order For Production Of Cell Banks Under Deal With Novavax

Mabion SA

14/01/2022 07:28

Jan 14 (Reuters) - Mabion SA  MABP.WA :
    * GETS ADDITIONAL ORDER FOR PRODUCTION OF CELL BANKS UNDER
DEAL
WITH NOVAVAX
    * PROJECT TO BE CARRIED OUT IN Q1
    * VALUE OF STATEMENT OF WORKS 3 IS NOT SIGNIFICANT VERSUS
ORIGINAL
PRODUCTION DEAL BUT EXPANDS COOPERATION WITH NOVAVAX INTO NEW
FIELD
    * UNDER STATEMENT OF WORK 3 COMPANY WILL PRODUCE BANK CELLS
BASED
ON GMP WHICH WILL BE USED AS KEY BIOLOGICAL MATERIAL IN
PRODUCING NOVAVAX VACCINE ANTIGENS 

Source text for Eikon:  ID:nEM3SfRMKa 
Further company coverage:  MABP.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))